Salman Bokhari joins InQpharm in a newly-created role as Global Sales and Business Development Director to further strengthen the senior management team. He will drive the international commercial strategy and direct the company's business development activities.
Salman brings extensive experience in general and regional management, marketing/sales and business development, having spent over 30 years with well-known pharmaceutical companies including Lundbeck, Schwarz Pharma, Perrigo and Ciba-Geigy/Novartis. He has achieved significant success in building winning teams and creating profitable and sustainable businesses. Salman holds a BA (Honours) in Economics and an MBA in international marketing. Having lived and worked in various countries, Salman is multi-cultural and multi-lingual.
In 2010, InQpharm achieved significant success and the company doubled the number of countries where its products are marketed. Salman's focus will be to identify and prioritise further opportunities for sustainable growth and to lead the commercial and business development efforts to capitalise entry into new markets as well as manage existing business partners.
Thomas Hafner, Chief Executive Officer, comments: "InQpharm commenced operations in 2005 and has achieved significant success in the last five years. Our products are available in every continent. We have a global R&D and manufacturing operation and a healthy product pipeline that focuses on areas of high unmet need. We have a range of innovative, natural and safe products that has expanded to three therapeutic areas: weight management, allergy management and gastro-intestinal health. In 2011 we launched our first gastro-intestinal product in Europe and we have several variants being launched in our weight management range.
Salman's appointment is important for the strategic development of our organisation and we are delighted to welcome him to our senior management team. He will be instrumental in helping us grow the business exponentially and develop our partner network."
For further information please email: enquiries@inqpharm.com